Microbiota intestinal y sus generalidades en el organismo del ser humano
La microbiota intestinal produce la mayoría de proteínas y minerales degradados que le sirven al cuerpo en los procesos metabólicos, en los últimos años se están adelantando ensayos científicos para avanzar en el conocimiento de una manera más práctica y definitiva en los problemas que se presentan en la parte gastrointestinal, uno de estos procedimientos son los trasplantes fecales que son de importancia para proponer un tratamiento contra el colon irritable y el cáncer de colon, todos estos problemas que afectan la salud de las personas. Otra propuesta de solución a estos problemas son los probióticos, que tienen la finalidad proporcionar a las bacterias benéficas encapsuladas en pastillas para que sean aprovechadas por el organismo con el fin de restaurar la microbiota de la persona afectada. En este artículo se pondrá en evidencia el interés y la importancia de la microbiota intestinal, además se expondrán sus diversas funciones de protección y defensa. Adema se incluye la relación con el sistema inmune, el cual al ser alterado por algún patógeno se ve comprometido produciendo diversidad de patologías que afectan el organismo de una manera severa causando desde la obesidad hasta la muerte.
F. Guarner. (2007). Papel de la flora intestinal en la salud y en la enfermedad-Role of intestinal flora in health and disease. Scielo. Disponible en http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=s0212-16112007000500003
Sirisinha S. The potential impact of gut microbiota on your health: Current status and future challenges. Asian Pacific J Allergy Immunol. 2016; 34(4):249–64.
PASSOS M do CF, MORAES-FILHO JP. Intestinal Microbiota in Digestive Diseases. Arq Gastroenterol [Internet]. 2017;54(3):255–62. Available from: http://www.scielo.br/
scielo.php?script=sci_arttext&pid=S0004-28032017000300255&lng=en&tlng=en
Lucas López R, Grande Burgos MJ, Gálvez A, Pérez Pulido R. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review. Apmis. 2017;125(1):3–10.
Alcock J, Maley CC, Aktipis CA. Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. BioEssays. 2014;36(10):940–9.
Shen L, Turner JR. Role of epithelial cells in initiation and propagation of intestinal
inflammation. Eliminating the static: tight junction dynamics exposed. Am J Physiol Gastrointest Liver Physiol 2006; 290: G577-82.
Mena, V. (2017). El intestino en el proceso salud/enfermedad. Rev Cubana Pediatr. 2017; 89 (2).
Bron PA, Kleerebezem M, Brummer R-J, Cani PD, Mercenier A, MacDonald TT, et al. Can
probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr [Internet]. 2017; 117(1):93–107. Available from: https://www.cambridge.org/core/product/identifier/S0007114516004037/type/journal_article
Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthésy B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 2002; 17: 107-15.
Strugnell RA, Wijburg OL. The role of secretoryvantibodies in infection immunity. Nat RevvMicrobiol 2010; 8: 656-67
Caricilli AM, Castoldi A, Câmara NO. Intestinal barrier: A gentlemen’s agreement between microbiota and immunity. World J Gastrointest Pathophysiol 2014; 5: 18-32.
Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer’s patch dendritic cells. J Immunol 2001; 166: 4884-90.
Farías N, M., Silva B, C., & Rozowski N, J. (2011). MICROBIOTA INTESTINAL: ROL EN OBESIDAD. Scielo. Retrieved 15 October 2017, from http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75182011000200013
Tinahones, F. (2017). La importancia de la microbiota en la obesidad. endocrinologiapediatrica.org. Retrieved 15 october 2017, from http://www.endocrinologiapediatrica.org/revistas/P1-E22/P1-E22-S1079-A394.pdf
Herrema, H., IJzerman, R., & Nieuwdorp, M. (2016). Emerging role of intestinal microbiota and microbial metabolites in metabolic control.Diabetologia, 2016 [citado 15 Oct 2017] 60(4), 613-617. Disponible en: https://link.springer.com/content/pdf/10.1007%2Fs00125-016-4192-0.pdf
Comparación del cultivo celular de HeLa y HEp- 2: perspectivas de estudios con Chlamydia trachomatis, Nova publicación Científica en Ciencias Biomédicas, página 19-31, ISNN 17942470, Indizada en Publindex A2, Scielo, REDALYC. 2012, PUBLICACIÓN 2015.
A.V. Gualteros Bustos; M. Gómez Jiménez; R.M. Sánchez Mora. The Annona muricata leaf ethanol extract affects mobility and reproduction in mutant strain NB327 Caenorhabditis elegans. Revista: Biochemistry and Biophysics Reports. Volume 10, July 2017, Pages 282-286.
Gualteros Bustos Andrea Vivana, Luz Adriana Monrroy, Lizeth Gonzalez Devia, Martha Gomez Jiménez, Sánchez Mora Ruth Mélida. Effect of Annona muricata on the phenotype of a mutant strain of Caenorhabditis elegans. Publicación: Biotechnology Summit 2016. Páginas 26-30ISBN: 978-607-9023-41-6.
Akbari P, Fink-Gremmels J, Willems RHAM, Difilippo E, Schols HA, Schoterman MHC, et al. Characterizing microbiota-independent effects of oligosaccharides on intestinal epithelial cells: insight into the role of structure and size: Structure–activity relationships of non-digestible oligosaccharides. Eur J Nutr. 2017;56(5):1919–30.
Korpela K, Mutanen A, Salonen A, Savilahti E, de Vos WM, Pakarinen MP. Intestinal Microbiota Signatures Associated With Histological Liver Steatosis in Pediatric-Onset Intestinal Failure. J Parenter Enter Nutr [Internet]. 2017;41(2):238–48. Available from: http://journals.sagepub.com/doi/10.1177/0148607115584388
Actis GC. The gut microbiome. Inflamm Allergy Drug Targets [Internet]. 2014;13(4):217–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24953716
Singh RK, Chang H-W, Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med [Internet]. 2017;15(1):73. Available from: http://translational-medicine.biomedcentral.com/articles/10.1186/s12967-017-1175-y
Paganini D, Uyoga MA, Kortman GAM, Cercamondi CI, Moretti D, Barth-Jaeggi T, et al. Prebiotic galacto-oligosaccharides mitigate the adverse effects of iron fortification on the gut microbiome: a randomised controlled study in Kenyan infants. Gut [Internet]. 2017; gutjnl-2017-314418. Available from: http://gut.bmj.com/lookup/doi/10.1136/gutjnl-2017-314418
Mehta M, Goldfarb DS, Nazzal L. The role of the microbiome in kidney stone formation. Int J Surg [Internet]. 2016; 36(PD):607–12. Available from: http://dx.doi.org/10.1016/j.ijsu.2016.11.02425. Czaja AJ. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis. World J Gastroenterol. 2016; 22(42):9257–78.
Yang L, Wang L, Wang X, Xian CJ, Caricilli Caricilli cup/doi/10.3945/an.116.012914
Parashar A, Udayabanu M. Gut microbiota: Implications in Parkinson’s disease. Parkinsonism Relat Disord [Internet]. 2017;38:1–7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1353802017300366
Hu S, Wang L, Jiang Z. Dietary Additive Probiotics Modulation of the Intestinal Microbiota. Protein Pept Lett [Internet]. 2017;24(5):382–7. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=0929-8665&volume=24&issue=5&spage=382
Łusiak-Szelachowska M, Weber-Dąbrowska B, Jończyk-Matysiak E, Wojciechowska R, Górski A. Bacteriophages in the gastrointestinal tract and their implications. Gut Pathog [Internet]. 2017;9(1):44. Available from: http://gutpathogens.biomedcentral.com/articles/10.1186/s13099-017-0196-7
El Aidy S, Ramsteijn AS, Dini-Andreote F, van Eijk R, Houwing DJ, Salles JF, et al. Serotonin Transporter Genotype Modulates the Gut Microbiota Composition in Young Rats, an Effect Augmented by Early Life Stress. Front Cell Neurosci [Internet]. 2017;11(August):1–12. Available from: http://journal.frontiersin.org/article/10.3389/fncel.2017.00222/full
Barba-Vidal E, Castillejos L, Roll VFB, Cifuentes- Orjuela G, Moreno Muñoz JA, Martín-Orúe SM. The Probiotic combination of Bifidobacterium longum subsp. infantis CECT 7210 and Bifidobacterium animalis subsp. lactis BPl6 reduces pathogen loads and improves gut health of weaned piglets orally challenged with Salmonella Typhimurium. Front Microbiol. 2017;8(AUG):1–13.
Rondon L, Añez M, Salvatierra A, Meneses RT, Heredia MT. Probióticos: generalidades. Arch Venez Pueric Pediatr [Internet]. 2015;78(4):123–8. Available from: http://www.scielo.org.ve/scielo.php?script=sci_arttext&pid=S0004-06492015000400006%0Ahttp://search.ebscohost.com/login.aspx?direct=true&site=edslive&db=edssci&AN=edssci.S0004.06492015000400006
Jenkins TP, Rathnayaka Y, Perera PK, Peachey LE, Nolan MJ, Krause L, et al. Infections by human gastrointestinal helminths are associated with changes in faecal microbiota diversity and composition. 2017;1–18.
Harris LA, Baffy N. Modulation of the gut microbiota: a focus on treatments for irritable
bowel syndrome. Postgrad Med [Internet]. 2017;129(8):1–17. Available from: https://doi.org/10.1080/00325481.2017.1383819
Barko PC, McMichael MA, Swanson KS, Williams DA. The Gastrointestinal Microbiome: A Review. J Vet Intern Med [Internet]. 2017; Available from: http://doi.wiley.com/10.1111/jvim.14875
Cui C, Li Y, Gao H, Zhang H, Han J, Zhang D, et al. Modulation of the gut microbiota by the mixture of fish oil and krill oil in high-fat diet-induced obesity mice. PLoS One. 2017;12(10):1–18.
Oh S, Yap GC, Hong PY, Huang CH, Aw MM, Shek LPC, et al. Immune-modulatory genomic properties differentiate gut microbiota of infants with and without eczema. PLoS One. 2017;12(10):1– 16.
Sánchez B, Delgado S, Blanco-Míguez A, Lourenço A, Gueimonde M, Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res. 2017;61(1):1–15
Bron PA, van Baarlen P, Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 2012; 10: 66-78
Flemer B, Lynch DB, Brown JMR, Jeffery IB, Ryan FJ, Claesson MJ, et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut [Internet]. 2017;66(4):633–43. Available from: http://gut.bmj.com/lookup/doi/10.1136/gutjnl-2015-309595
Yang CA, Liang C, Lin CL, Hsiao CT, Peng CT, Lin HC, et al. Impact of Enterobius vermicularis infection and mebendazole treatment on intestinal microbiota and host immune response. PLoS Negl Trop Dis. 2017;11(9):1–16.
Kaczmarek JL, Musaad SMA, Holscher HD. Time of day and eating behaviors are associated with the composition and function of the human gastrointestinal microbiota. Am J Clin Nutr. 2017;106(5):1220–31.
Vella A, Camilleri M. The Gastrointestinal Tract as an Integrator of Mechanical and Hormonal Response to Nutrient Ingestion. Diabetes [Internet]. 2017;66(11):2729–37. Available from: http://diabetes.diabetesjournals.org/lookup/doi/10.2337/dbi17-0021
Pagliari D, Piccirillo CA, Larbi A, Cianci R. The Interactions between Innate Immunity and Microbiota in Gastrointestinal Diseases. J Immunol Res. 2015;2015.
Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J, et al. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome [Internet]. 2017;5(1):24. Available from: http://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-017-0242-1
Alarcón P, González M, Castro É. Rol de la microbiota gastrointestinal en la regulación de la respuesta inmune. Rev Med Chil. 2016;144(7):910– 6.
Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J [Internet].
;474(11):1823–36. Available from: http://biochemj.org/lookup/doi/10.1042/BCJ20160510
Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome [Internet]. 2017;5(1):14. Available from: http://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-016-0222-x
Shubach APJ, Devia JLG, Mora RMS. Asociación de HSP60 de Chlamydia trachomatis y desarrollo de cáncer de ovario. Nova [Internet]. 2017;15(28):57–
Available from: http://hemeroteca.unad.edu.co/index.php/nova/article/view/2079
Mantilla A, Olave LF, Paola A, Shubach, Jutinico MR. Determinación de IgG contra Chlamydya trachomatis en mujeres con artritis de la Ciudad de Bogotá D . C . Un estudio piloto. :27–34.
